Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine for Postoperative Pain in Thoracoscopic Surgery
NCT03677817Phase 3Completed
- Sponsor
- University Hospital Basel
- Start
- Apr 2019
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Lidocaine with Placebo (2 arms). Primary endpoints: Total Morphine Consumption at 24 hours and Pain Intensity at 24 hours. Started Apr 2019; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03677817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03677817.